Stock of cancer lab takes a hit


  • By
  • | 5:39 p.m. February 20, 2014
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — A possible change in future government reimbursements for cancer tests caused NeoGenomics shares to fall 14% on Wednesday.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content